<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-12-02" version="174">
<accession>Q10589</accession>
<accession>A8K4Y4</accession>
<accession>Q53G07</accession>
<name>BST2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Bone marrow stromal antigen 2</fullName>
<shortName>BST-2</shortName>
</recommendedName>
<alternativeName>
<fullName>HM1.24 antigen</fullName>
</alternativeName>
<alternativeName>
<fullName>Tetherin</fullName>
</alternativeName>
<cdAntigenName>CD317</cdAntigenName>
</protein>
<gene>
<name type="primary">BST2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Genomics" volume="26" first="527" last="534">
<title>Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth.</title>
<authorList>
<person name="Ishikawa J."/>
<person name="Kaisho T."/>
<person name="Tomizawa H."/>
<person name="Lee B.O."/>
<person name="Kobune Y."/>
<person name="Inazawa J."/>
<person name="Oritani K."/>
<person name="Itoh M."/>
<person name="Ochi T."/>
<person name="Ishihara K."/>
<person name="Hirano T."/>
</authorList>
<dbReference type="PubMed" id="7607676"/>
<dbReference type="DOI" id="10.1016/0888-7543(95)80171-h"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="258" first="583" last="591">
<title>Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells.</title>
<authorList>
<person name="Ohtomo T."/>
<person name="Sugamata Y."/>
<person name="Ozaki Y."/>
<person name="Ono K."/>
<person name="Yoshimura Y."/>
<person name="Kawai S."/>
<person name="Koishihara Y."/>
<person name="Ozaki S."/>
<person name="Kosaka M."/>
<person name="Hirano T."/>
<person name="Tsuchiya M."/>
</authorList>
<dbReference type="PubMed" id="10329429"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0683"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Cell. Immunol." volume="236" first="6" last="16">
<title>Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry.</title>
<authorList>
<person name="Vidal-Laliena M."/>
<person name="Romero X."/>
<person name="March S."/>
<person name="Requena V."/>
<person name="Petriz J."/>
<person name="Engel P."/>
</authorList>
<dbReference type="PubMed" id="16157322"/>
<dbReference type="DOI" id="10.1016/j.cellimm.2005.08.002"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION BY B-CELL ACTIVATION</scope>
<scope>NOMENCLATURE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="935" last="943">
<title>Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment.</title>
<authorList>
<person name="Elortza F."/>
<person name="Mohammed S."/>
<person name="Bunkenborg J."/>
<person name="Foster L.J."/>
<person name="Nuehse T.S."/>
<person name="Brodbeck U."/>
<person name="Peck S.C."/>
<person name="Jensen O.N."/>
</authorList>
<dbReference type="PubMed" id="16602701"/>
<dbReference type="DOI" id="10.1021/pr050419u"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>GPI-ANCHOR [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Proteomics" volume="7" first="1951" last="1960">
<title>Computational approach for identification and characterization of GPI-anchored peptides in proteomics experiments.</title>
<authorList>
<person name="Omaetxebarria M.J."/>
<person name="Elortza F."/>
<person name="Rodriguez-Suarez E."/>
<person name="Aloria K."/>
<person name="Arizmendi J.M."/>
<person name="Jensen O.N."/>
<person name="Matthiesen R."/>
</authorList>
<dbReference type="PubMed" id="17566972"/>
<dbReference type="DOI" id="10.1002/pmic.200700068"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Cell Host Microbe" volume="3" first="245" last="252">
<title>The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.</title>
<authorList>
<person name="Van Damme N."/>
<person name="Goff D."/>
<person name="Katsura C."/>
<person name="Jorgenson R.L."/>
<person name="Mitchell R."/>
<person name="Johnson M.C."/>
<person name="Stephens E.B."/>
<person name="Guatelli J."/>
</authorList>
<dbReference type="PubMed" id="18342597"/>
<dbReference type="DOI" id="10.1016/j.chom.2008.03.001"/>
</citation>
<scope>FUNCTION IN HIV-1 INFECTION</scope>
<scope>INDUCTION BY HIV-1 VPU (MICROBIAL INFECTION)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Nature" volume="451" first="425" last="430">
<title>Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.</title>
<authorList>
<person name="Neil S.J."/>
<person name="Zang T."/>
<person name="Bieniasz P.D."/>
</authorList>
<dbReference type="PubMed" id="18200009"/>
<dbReference type="DOI" id="10.1038/nature06553"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION NY HIV-1 VPU (MICROBIAL INFECTION)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="Cell" volume="139" first="499" last="511">
<title>Tetherin inhibits HIV-1 release by directly tethering virions to cells.</title>
<authorList>
<person name="Perez-Caballero D."/>
<person name="Zang T."/>
<person name="Ebrahimi A."/>
<person name="McNatt M.W."/>
<person name="Gregory D.A."/>
<person name="Johnson M.C."/>
<person name="Bieniasz P.D."/>
</authorList>
<dbReference type="PubMed" id="19879838"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.08.039"/>
</citation>
<scope>FUNCTION IN HIV-1 INFECTION</scope>
<scope>GLYCOSYLATION AT ASN-65 AND ASN-92</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
<scope>TOPOLOGY</scope>
<scope>GPI-ANCHOR</scope>
<scope>MUTAGENESIS OF ASN-65 AND ASN-92</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Cell Host Microbe" volume="6" first="393" last="395">
<title>A tail of Tetherin: how pandemic HIV-1 conquered the world.</title>
<authorList>
<person name="Gupta R.K."/>
<person name="Towers G.J."/>
</authorList>
<dbReference type="PubMed" id="19917491"/>
<dbReference type="DOI" id="10.1016/j.chom.2009.11.002"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="35060" last="35072">
<title>HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.</title>
<authorList>
<person name="Iwabu Y."/>
<person name="Fujita H."/>
<person name="Kinomoto M."/>
<person name="Kaneko K."/>
<person name="Ishizaka Y."/>
<person name="Tanaka Y."/>
<person name="Sata T."/>
<person name="Tokunaga K."/>
</authorList>
<dbReference type="PubMed" id="19837671"/>
<dbReference type="DOI" id="10.1074/jbc.m109.058305"/>
</citation>
<scope>INTERACTION WITH HIV-1 VPU (MICROBIAL INFECTION)</scope>
<scope>INDUCTION BY HIV-1 VPU (MICROBIAL INFECTION)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="J. Exp. Med." volume="206" first="1603" last="1614">
<title>Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.</title>
<authorList>
<person name="Cao W."/>
<person name="Bover L."/>
<person name="Cho M."/>
<person name="Wen X."/>
<person name="Hanabuchi S."/>
<person name="Bao M."/>
<person name="Rosen D.B."/>
<person name="Wang Y.H."/>
<person name="Shaw J.L."/>
<person name="Du Q."/>
<person name="Li C."/>
<person name="Arai N."/>
<person name="Yao Z."/>
<person name="Lanier L.L."/>
<person name="Liu Y.J."/>
</authorList>
<dbReference type="PubMed" id="19564354"/>
<dbReference type="DOI" id="10.1084/jem.20090547"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH LILRA4/ILT7</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-65</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="1837" last="1844">
<title>Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.</title>
<authorList>
<person name="Jouvenet N."/>
<person name="Neil S.J."/>
<person name="Zhadina M."/>
<person name="Zang T."/>
<person name="Kratovac Z."/>
<person name="Lee Y."/>
<person name="McNatt M."/>
<person name="Hatziioannou T."/>
<person name="Bieniasz P.D."/>
</authorList>
<dbReference type="PubMed" id="19036818"/>
<dbReference type="DOI" id="10.1128/jvi.02211-08"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="11966" last="11978">
<title>Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.</title>
<authorList>
<person name="Le Tortorec A."/>
<person name="Neil S.J."/>
</authorList>
<dbReference type="PubMed" id="19740980"/>
<dbReference type="DOI" id="10.1128/jvi.01515-09"/>
</citation>
<scope>INTERACTION WITH HIV-2 ENV (MICROBIAL INFECTION)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INDUCTION BY HIV-2 ENV (MICROBIAL INFECTION)</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-65</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="2886" last="2891">
<title>Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.</title>
<authorList>
<person name="Kaletsky R.L."/>
<person name="Francica J.R."/>
<person name="Agrawal-Gamse C."/>
<person name="Bates P."/>
</authorList>
<dbReference type="PubMed" id="19179289"/>
<dbReference type="DOI" id="10.1073/pnas.0811014106"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EBOLA GP PROTEIN (MICROBIAL INFECTION)</scope>
<scope>INDUCTION BY EBOLA GP PROTEIN (MICROBIAL INFECTION)</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Retrovirology" volume="6" first="80" last="80">
<title>The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu.</title>
<authorList>
<person name="Andrew A.J."/>
<person name="Miyagi E."/>
<person name="Kao S."/>
<person name="Strebel K."/>
</authorList>
<dbReference type="PubMed" id="19737401"/>
<dbReference type="DOI" id="10.1186/1742-4690-6-80"/>
</citation>
<scope>GLYCOSYLATION AT ASN-65 AND ASN-92</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="10569" last="10580">
<title>Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.</title>
<authorList>
<person name="Radoshitzky S.R."/>
<person name="Dong L."/>
<person name="Chi X."/>
<person name="Clester J.C."/>
<person name="Retterer C."/>
<person name="Spurgers K."/>
<person name="Kuhn J.H."/>
<person name="Sandwick S."/>
<person name="Ruthel G."/>
<person name="Kota K."/>
<person name="Boltz D."/>
<person name="Warren T."/>
<person name="Kranzusch P.J."/>
<person name="Whelan S.P."/>
<person name="Bavari S."/>
</authorList>
<dbReference type="PubMed" id="20686043"/>
<dbReference type="DOI" id="10.1128/jvi.00103-10"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="J. Virol." volume="84" first="12646" last="12657">
<title>Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.</title>
<authorList>
<person name="Weidner J.M."/>
<person name="Jiang D."/>
<person name="Pan X.B."/>
<person name="Chang J."/>
<person name="Block T.M."/>
<person name="Guo J.T."/>
</authorList>
<dbReference type="PubMed" id="20943977"/>
<dbReference type="DOI" id="10.1128/jvi.01328-10"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="PLoS Pathog." volume="6" first="E1000843" last="E1000843">
<title>The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.</title>
<authorList>
<person name="Pardieu C."/>
<person name="Vigan R."/>
<person name="Wilson S.J."/>
<person name="Calvi A."/>
<person name="Zang T."/>
<person name="Bieniasz P."/>
<person name="Kellam P."/>
<person name="Towers G.J."/>
<person name="Neil S.J."/>
</authorList>
<dbReference type="PubMed" id="20419159"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000843"/>
</citation>
<scope>FUNCTION IN KSHV AND HIV-1 INFECTION</scope>
<scope>SUBCELLULAR LOCATION (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF LYS-18 AND LYS-21</scope>
<scope>UBIQUITINATION AT LYS-18 BY KSH VIRUS E3 UBIQUITIN-PROTEIN LIGASE K5 (MICROBIAL INFECTION)</scope>
<scope>INDUCTION BY KSHV K5 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Trends Microbiol." volume="18" first="388" last="396">
<title>BST-2/tetherin: a new component of the innate immune response to enveloped viruses.</title>
<authorList>
<person name="Evans D.T."/>
<person name="Serra-Moreno R."/>
<person name="Singh R.K."/>
<person name="Guatelli J.C."/>
</authorList>
<dbReference type="PubMed" id="20688520"/>
<dbReference type="DOI" id="10.1016/j.tim.2010.06.010"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Front. Microbiol." volume="2" first="250" last="250">
<title>structural basis for the antiviral activity of Bst-2/tetherin and its viral antagonism.</title>
<authorList>
<person name="Arias J.F."/>
<person name="Iwabu Y."/>
<person name="Tokunaga K."/>
</authorList>
<dbReference type="PubMed" id="22180752"/>
<dbReference type="DOI" id="10.3389/fmicb.2011.00250"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="J. Interferon Cytokine Res." volume="31" first="137" last="144">
<title>The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?</title>
<authorList>
<person name="Andrew A."/>
<person name="Strebel K."/>
</authorList>
<dbReference type="PubMed" id="21166593"/>
<dbReference type="DOI" id="10.1089/jir.2010.0108"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="J. Neuroimmun. Pharmacol." volume="6" first="188" last="201">
<title>Tetherin and its viral antagonists.</title>
<authorList>
<person name="Kuhl B.D."/>
<person name="Cheng V."/>
<person name="Wainberg M.A."/>
<person name="Liang C."/>
</authorList>
<dbReference type="PubMed" id="21222046"/>
<dbReference type="DOI" id="10.1007/s11481-010-9256-1"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Virol. J." volume="8" first="198" last="198">
<title>Tetherin inhibits prototypic foamy virus release.</title>
<authorList>
<person name="Xu F."/>
<person name="Tan J."/>
<person name="Liu R."/>
<person name="Xu D."/>
<person name="Li Y."/>
<person name="Geng Y."/>
<person name="Liang C."/>
<person name="Qiao W."/>
</authorList>
<dbReference type="PubMed" id="21529378"/>
<dbReference type="DOI" id="10.1186/1743-422x-8-198"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Virology" volume="417" first="50" last="56">
<title>Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin.</title>
<authorList>
<person name="Watanabe R."/>
<person name="Leser G.P."/>
<person name="Lamb R.A."/>
</authorList>
<dbReference type="PubMed" id="21621240"/>
<dbReference type="DOI" id="10.1016/j.virol.2011.05.006"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Viruses" volume="3" first="520" last="540">
<title>Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction.</title>
<authorList>
<person name="Le Tortorec A."/>
<person name="Willey S."/>
<person name="Neil S.J."/>
</authorList>
<dbReference type="PubMed" id="21994744"/>
<dbReference type="DOI" id="10.3390/v3050520"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2012" name="Front. Microbiol." volume="3" first="131" last="131">
<title>Vpu and BST2: still not there yet?</title>
<authorList>
<person name="Sato K."/>
<person name="Gee P."/>
<person name="Koyanagi Y."/>
</authorList>
<dbReference type="PubMed" id="22509177"/>
<dbReference type="DOI" id="10.3389/fmicb.2012.00131"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2012" name="J. Cell. Biochem." volume="113" first="1013" last="1021">
<title>BST-2 binding with cellular MT1-MMP blocks cell growth and migration via decreasing MMP2 activity.</title>
<authorList>
<person name="Gu G."/>
<person name="Zhao D."/>
<person name="Yin Z."/>
<person name="Liu P."/>
</authorList>
<dbReference type="PubMed" id="22065321"/>
<dbReference type="DOI" id="10.1002/jcb.23433"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MMP14</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2012" name="Mol. Biol. Int." volume="2012" first="424768" last="424768">
<title>Restriction of retroviral replication by tetherin/BST-2.</title>
<authorList>
<person name="Hammonds J."/>
<person name="Wang J.J."/>
<person name="Spearman P."/>
</authorList>
<dbReference type="PubMed" id="22811908"/>
<dbReference type="DOI" id="10.1155/2012/424768"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2012" name="PLoS Pathog." volume="8" first="E1002931" last="E1002931">
<title>Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities.</title>
<authorList>
<person name="Cocka L.J."/>
<person name="Bates P."/>
</authorList>
<dbReference type="PubMed" id="23028328"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1002931"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>ALTERNATIVE INITIATION (ISOFORMS 1 AND 2)</scope>
<scope>INDUCTION</scope>
<scope>MUTAGENESIS OF 3-SER--SER-5; TYR-6 AND TYR-8</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="Virology" volume="428" first="98" last="111">
<title>Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin.</title>
<authorList>
<person name="Dafa-Berger A."/>
<person name="Kuzmina A."/>
<person name="Fassler M."/>
<person name="Yitzhak-Asraf H."/>
<person name="Shemer-Avni Y."/>
<person name="Taube R."/>
</authorList>
<dbReference type="PubMed" id="22520941"/>
<dbReference type="DOI" id="10.1016/j.virol.2012.03.011"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2015" name="PLoS Pathog." volume="11" first="E1005024" last="E1005024">
<title>Vpu exploits the cross-talk between BST2 and the ILT7 receptor to suppress anti-HIV-1 responses by plasmacytoid dendritic Cells.</title>
<authorList>
<person name="Bego M.G."/>
<person name="Cote E."/>
<person name="Aschman N."/>
<person name="Mercier J."/>
<person name="Weissenhorn W."/>
<person name="Cohen E.A."/>
</authorList>
<dbReference type="PubMed" id="26172439"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1005024"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBCELLULAR LOCATION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH LILRA4</scope>
<scope>GPI-ANCHOR</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2015" name="J. Virol." volume="89" first="11820" last="11833">
<title>Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.</title>
<authorList>
<person name="Taylor J.K."/>
<person name="Coleman C.M."/>
<person name="Postel S."/>
<person name="Sisk J.M."/>
<person name="Bernbaum J.G."/>
<person name="Venkataraman T."/>
<person name="Sundberg E.J."/>
<person name="Frieman M.B."/>
</authorList>
<dbReference type="PubMed" id="26378163"/>
<dbReference type="DOI" id="10.1128/jvi.02274-15"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH SARS-COV ORF7A PROTEIN (MICROBIAL INFECTION)</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2019" name="J. Med. Virol." volume="91" first="1743" last="1750">
<title>Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release.</title>
<authorList>
<person name="Wang S.M."/>
<person name="Huang K.J."/>
<person name="Wang C.T."/>
</authorList>
<dbReference type="PubMed" id="31199522"/>
<dbReference type="DOI" id="10.1002/jmv.25518"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION (MICROBIAL INFECTION)</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF CYS-53; CYS-63 AND CYS-91</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Cell Host Microbe" volume="7" first="314" last="323">
<title>Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain.</title>
<authorList>
<person name="Hinz A."/>
<person name="Miguet N."/>
<person name="Natrajan G."/>
<person name="Usami Y."/>
<person name="Yamanaka H."/>
<person name="Renesto P."/>
<person name="Hartlieb B."/>
<person name="McCarthy A.A."/>
<person name="Simorre J.P."/>
<person name="Gottlinger H."/>
<person name="Weissenhorn W."/>
</authorList>
<dbReference type="PubMed" id="20399176"/>
<dbReference type="DOI" id="10.1016/j.chom.2010.03.005"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.77 ANGSTROMS) OF 87-147</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CIRCULAR DICHROISM</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="17951" last="17956">
<title>Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations.</title>
<authorList>
<person name="Schubert H.L."/>
<person name="Zhai Q."/>
<person name="Sandrin V."/>
<person name="Eckert D.M."/>
<person name="Garcia-Maya M."/>
<person name="Saul L."/>
<person name="Sundquist W.I."/>
<person name="Steiner R.A."/>
<person name="Hill C.P."/>
</authorList>
<dbReference type="PubMed" id="20880831"/>
<dbReference type="DOI" id="10.1073/pnas.1008206107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 47-152</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="18428" last="18432">
<title>Structural insight into the mechanisms of enveloped virus tethering by tetherin.</title>
<authorList>
<person name="Yang H."/>
<person name="Wang J."/>
<person name="Jia X."/>
<person name="McNatt M.W."/>
<person name="Zang T."/>
<person name="Pan B."/>
<person name="Meng W."/>
<person name="Wang H.W."/>
<person name="Bieniasz P.D."/>
<person name="Xiong Y."/>
</authorList>
<dbReference type="PubMed" id="20940320"/>
<dbReference type="DOI" id="10.1073/pnas.1011485107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 47-161</scope>
<scope>SUBUNIT</scope>
<scope>FUNCTION</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<comment type="function">
<text evidence="9 10 11 13 15 19 20 21 22 24 25 26 27 28 29 30 31 32 33">IFN-induced antiviral host restriction factor which efficiently blocks the release of diverse mammalian enveloped viruses by directly tethering nascent virions to the membranes of infected cells. Acts as a direct physical tether, holding virions to the cell membrane and linking virions to each other. The tethered virions can be internalized by endocytosis and subsequently degraded or they can remain on the cell surface. In either case, their spread as cell-free virions is restricted (PubMed:22520941, PubMed:21529378, PubMed:20940320, PubMed:20419159, PubMed:20399176, PubMed:19879838, PubMed:19036818, PubMed:18342597, PubMed:18200009). Its target viruses belong to diverse families, including retroviridae: human immunodeficiency virus type 1 (HIV-1), human immunodeficiency virus type 2 (HIV-2), simian immunodeficiency viruses (SIVs), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), prototype foamy virus (PFV), Mason-Pfizer monkey virus (MPMV), human T-cell leukemia virus type 1 (HTLV-1), Rous sarcoma virus (RSV) and murine leukemia virus (MLV), flavivirideae: hepatitis C virus (HCV), filoviridae: ebola virus (EBOV) and marburg virus (MARV), arenaviridae: lassa virus (LASV) and machupo virus (MACV), herpesviridae: kaposis sarcoma-associated herpesvirus (KSHV), rhabdoviridae: vesicular stomatitis virus (VSV), orthomyxoviridae: influenza A virus, paramyxoviridae: nipah virus, and coronaviridae: SARS-CoV (PubMed:22520941, PubMed:21621240, PubMed:21529378, PubMed:20943977, PubMed:20686043, PubMed:20419159, PubMed:20399176, PubMed:19879838, PubMed:19179289, PubMed:18342597, PubMed:18200009, PubMed:26378163, PubMed:31199522). Can inhibit cell surface proteolytic activity of MMP14 causing decreased activation of MMP15 which results in inhibition of cell growth and migration (PubMed:22065321). Can stimulate signaling by LILRA4/ILT7 and consequently provide negative feedback to the production of IFN by plasmacytoid dendritic cells in response to viral infection (PubMed:19564354, PubMed:26172439). Plays a role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. Isoform 1 and isoform 2 are both effective viral restriction factors but have differing antiviral and signaling activities (PubMed:23028328, PubMed:26172439). Isoform 2 is resistant to HIV-1 Vpu-mediated degradation and restricts HIV-1 viral budding in the presence of Vpu (PubMed:23028328, PubMed:26172439). Isoform 1 acts as an activator of NF-kappa-B and this activity is inhibited by isoform 2 (PubMed:23028328).</text>
</comment>
<comment type="subunit">
<text evidence="5 7 15 16 19 20 23 24 28 30 32 33">Parallel homodimer; disulfide-linked. May form homotetramers under reducing conditions. Isoform 1 and isoform 2 form homodimers and also heterodimers with each other. Dimerization is essential for its antiviral activity (PubMed:26378163, PubMed:10329429, PubMed:19737401, PubMed:19879838, PubMed:23028328, PubMed:20399176, PubMed:20880831, PubMed:20940320, PubMed:31199522). Interacts (via cytoplasmic domain) with ARHGAP44 (By similarity). Interacts with MMP14 (via C-terminal cytoplasmic tail) (PubMed:22065321). Interacts with LILRA4/ILT7 (PubMed:19564354).</text>
</comment>
<comment type="subunit">
<text evidence="13">(Microbial infection) Interacts with ebola GP protein.</text>
</comment>
<comment type="subunit">
<text evidence="18">(Microbial infection) Interacts (via transmembrane domain) with HIV-1 VPU (via transmembrane domain).</text>
</comment>
<comment type="subunit">
<text evidence="17">(Microbial infection) Interacts with HIV-2 ENV.</text>
</comment>
<comment type="subunit">
<text evidence="32">(Microbial infection) Interacts with SARS-CoV ORF7a protein.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2476339">
<id>Q10589</id>
</interactant>
<interactant intactId="EBI-2476339">
<id>Q10589</id>
<label>BST2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2476339">
<id>Q10589</id>
</interactant>
<interactant intactId="EBI-712921">
<id>P60033</id>
<label>CD81</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2476339">
<id>Q10589</id>
</interactant>
<interactant intactId="EBI-2841591">
<id>P59901</id>
<label>LILRA4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2476339">
<id>Q10589</id>
</interactant>
<interactant intactId="EBI-1040251">
<id>P35585</id>
<label>Ap1m1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2476339">
<id>Q10589</id>
</interactant>
<interactant intactId="EBI-15754841">
<id>A9QPL9</id>
<label>GP</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2476339">
<id>Q10589</id>
</interactant>
<interactant intactId="EBI-10757638">
<id>P69699</id>
<label>vpu</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Golgi apparatus</location>
<location>trans-Golgi network</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Cell membrane</location>
<topology>Single-pass type II membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 31">Cell membrane</location>
<topology evidence="19 36">Lipid-anchor</topology>
<topology evidence="19 36">GPI-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location>Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="4">Apical cell membrane</location>
</subcellularLocation>
<text>Shuttles between the cell membrane, where it is present predominantly in membrane/lipid rafts, and the trans-Golgi network. Forms a complex with MMP14 and localizes to the cytoplasm.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="31">Golgi apparatus</location>
<location evidence="31">trans-Golgi network</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="21">Late endosome</location>
</subcellularLocation>
<text evidence="21 31">(Microbial infection) HIV-1 VPU and HIV-2 ENV can target it to the trans-Golgi network thus sequestering it away from virus assembly sites on the cell membrane. Targeted to late endosomes upon KSHV infection and subsequent ubiquitination.</text>
</comment>
<comment type="alternative products">
<event type="alternative initiation"/>
<isoform>
<id>Q10589-1</id>
<name>1</name>
<name>l-Tetherin</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q10589-2</id>
<name>2</name>
<name>s-Tetherin</name>
<sequence type="described" ref="VSP_053250"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="7 8">Predominantly expressed in liver, lung, heart and placenta. Lower levels in pancreas, kidney, skeletal muscle and brain. Overexpressed in multiple myeloma cells. Highly expressed during B-cell development, from pro-B precursors to plasma cells. Highly expressed on T-cells, monocytes, NK cells and dendritic cells (at protein level).</text>
</comment>
<comment type="induction">
<text evidence="8 30">By type I interferons.</text>
</comment>
<comment type="induction">
<text evidence="9 10 18">(Microbial infection) Down-regulated by HIV-1 VPU protein. Antagonizes its function by targeting it to the trans-Golgi network, sequestering it away from virus assembly sites on the cell membrane. VPU also acts as an adapter molecule linking it to BTRC, a substrate recognition subunit of the Skp1/Cullin/F-box protein E3 ubiquitin ligase, inducing its ubiquitination and subsequent proteasomal degradation.</text>
</comment>
<comment type="induction">
<text evidence="17">(Microbial infection) Down-regulated by HIV-2 ENV protein. Antagonizes its function by targeting it to the trans-Golgi network, sequestering it away from virus assembly sites on the cell membrane.</text>
</comment>
<comment type="induction">
<text evidence="21">(Microbial infection) Down-regulated by KSHV K5 protein. K5 ubiquitinates it leading to its targeting to late endosomes and degradation.</text>
</comment>
<comment type="induction">
<text evidence="13">(Microbial infection) Down-regulated by ebola virus GP protein.</text>
</comment>
<comment type="induction">
<text evidence="32 33">(Microbial infection) Made inactive by SARS-CoV ORF7a protein through impairing proper glycosylation (PubMed:26378163). May be down-regulated by SARS-CoV Spike protein through lysosomal degradation pathway (PubMed:31199522).</text>
</comment>
<comment type="domain">
<text evidence="20">The extracellular coiled coil domain forms an extended 170 A long semi-flexible rod-like structure important for virion retention at the cell surface and prevention of virus spreading.</text>
</comment>
<comment type="PTM">
<text evidence="21">Monoubiquitinated by KSHV E3 ubiquitin-protein ligase K5, leading to its targeting to late endosomes and degradation.</text>
</comment>
<comment type="PTM">
<text>The GPI anchor is essential for its antiviral activity.</text>
</comment>
<comment type="miscellaneous">
<text evidence="35">Tetherin shows evidence of positive (adaptive) selection, presumably as a result of evolutionary pressure applied by antagonistic viral proteins that counteract its inhibitiory activity and this has led to the species-specific tetherin sensitivity to viral countermeasures. For example, Tantalus monkey tetherin cannot be abrogated by HIV-1 VPU due to variation in the tetherin transmembrane region. Similarly, SIV Nefs are able to overcome simian tetherins, but not human tetherin, due to a unique 5-amino-acid deletion in the cytoplasmic tail domain of human tetherin (PubMed:19917491).</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="34">Produced by alternative initiation at Met-13 of isoform 1.</text>
</comment>
<comment type="similarity">
<text evidence="34">Belongs to the tetherin family.</text>
</comment>
<dbReference type="EMBL" id="D28137">
<property type="protein sequence ID" value="BAA05679.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223124">
<property type="protein sequence ID" value="BAD96844.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291099">
<property type="protein sequence ID" value="BAF83788.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC010319">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471106">
<property type="protein sequence ID" value="EAW84602.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033873">
<property type="protein sequence ID" value="AAH33873.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12358.1">
<molecule id="Q10589-1"/>
</dbReference>
<dbReference type="PIR" id="A56836">
<property type="entry name" value="A56836"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004326.1">
<molecule id="Q10589-1"/>
<property type="nucleotide sequence ID" value="NM_004335.3"/>
</dbReference>
<dbReference type="PDB" id="2LK9">
<property type="method" value="NMR"/>
<property type="chains" value="A=18-47"/>
</dbReference>
<dbReference type="PDB" id="2X7A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.77"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K=87-147"/>
</dbReference>
<dbReference type="PDB" id="2XG7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.45"/>
<property type="chains" value="A/C=51-151"/>
</dbReference>
<dbReference type="PDB" id="3MQ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.28"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=47-161"/>
</dbReference>
<dbReference type="PDB" id="3MQ9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D/E/F/G/H=66-139"/>
</dbReference>
<dbReference type="PDB" id="3MQB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/E/F=47-161"/>
</dbReference>
<dbReference type="PDB" id="3MQC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D=47-161"/>
</dbReference>
<dbReference type="PDB" id="3NWH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=47-152"/>
</dbReference>
<dbReference type="PDB" id="4P6Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="T=1-21"/>
</dbReference>
<dbReference type="PDB" id="6CM9">
<property type="method" value="EM"/>
<property type="resolution" value="3.73"/>
<property type="chains" value="L/N/T=2-21"/>
</dbReference>
<dbReference type="PDB" id="6CRI">
<property type="method" value="EM"/>
<property type="resolution" value="6.80"/>
<property type="chains" value="N/T/Y/Z/c/d=2-21"/>
</dbReference>
<dbReference type="PDB" id="6D83">
<property type="method" value="EM"/>
<property type="resolution" value="4.27"/>
<property type="chains" value="L/T=2-21"/>
</dbReference>
<dbReference type="PDB" id="6D84">
<property type="method" value="EM"/>
<property type="resolution" value="6.72"/>
<property type="chains" value="L/O/R/T=2-21"/>
</dbReference>
<dbReference type="PDB" id="6DFF">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="L/T=2-21"/>
</dbReference>
<dbReference type="PDBsum" id="2LK9"/>
<dbReference type="PDBsum" id="2X7A"/>
<dbReference type="PDBsum" id="2XG7"/>
<dbReference type="PDBsum" id="3MQ7"/>
<dbReference type="PDBsum" id="3MQ9"/>
<dbReference type="PDBsum" id="3MQB"/>
<dbReference type="PDBsum" id="3MQC"/>
<dbReference type="PDBsum" id="3NWH"/>
<dbReference type="PDBsum" id="4P6Z"/>
<dbReference type="PDBsum" id="6CM9"/>
<dbReference type="PDBsum" id="6CRI"/>
<dbReference type="PDBsum" id="6D83"/>
<dbReference type="PDBsum" id="6D84"/>
<dbReference type="PDBsum" id="6DFF"/>
<dbReference type="BMRB" id="Q10589"/>
<dbReference type="SMR" id="Q10589"/>
<dbReference type="BioGRID" id="107149">
<property type="interactions" value="31"/>
</dbReference>
<dbReference type="DIP" id="DIP-53216N"/>
<dbReference type="IntAct" id="Q10589">
<property type="interactions" value="27"/>
</dbReference>
<dbReference type="MINT" id="Q10589"/>
<dbReference type="STRING" id="9606.ENSP00000252593"/>
<dbReference type="TCDB" id="1.D.118.1.1">
<property type="family name" value="the pore-forming b18 peptide derived from the b49mod1 protein (b49-b18) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1044">
<property type="glycosylation" value="11 N-Linked glycans (2 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="Q10589">
<property type="glycosylation" value="2 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q10589"/>
<dbReference type="PhosphoSitePlus" id="Q10589"/>
<dbReference type="SwissPalm" id="Q10589"/>
<dbReference type="BioMuta" id="BST2"/>
<dbReference type="DMDM" id="1705508"/>
<dbReference type="EPD" id="Q10589"/>
<dbReference type="jPOST" id="Q10589"/>
<dbReference type="MassIVE" id="Q10589"/>
<dbReference type="MaxQB" id="Q10589"/>
<dbReference type="PaxDb" id="Q10589"/>
<dbReference type="PeptideAtlas" id="Q10589"/>
<dbReference type="PRIDE" id="Q10589"/>
<dbReference type="ProteomicsDB" id="58866">
<molecule id="Q10589-1"/>
</dbReference>
<dbReference type="ABCD" id="Q10589">
<property type="antibodies" value="23 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="1532">
<property type="antibodies" value="672 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="684"/>
<dbReference type="Ensembl" id="ENST00000252593">
<molecule id="Q10589-1"/>
<property type="protein sequence ID" value="ENSP00000252593"/>
<property type="gene ID" value="ENSG00000130303"/>
</dbReference>
<dbReference type="GeneID" id="684"/>
<dbReference type="KEGG" id="hsa:684"/>
<dbReference type="UCSC" id="uc060vid.1">
<molecule id="Q10589-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="684"/>
<dbReference type="DisGeNET" id="684"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000130303.12"/>
<dbReference type="GeneCards" id="BST2"/>
<dbReference type="HGNC" id="HGNC:1119">
<property type="gene designation" value="BST2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000130303">
<property type="expression patterns" value="Tissue enhanced (ovary)"/>
</dbReference>
<dbReference type="MIM" id="600534">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q10589"/>
<dbReference type="OpenTargets" id="ENSG00000130303"/>
<dbReference type="PharmGKB" id="PA25436"/>
<dbReference type="eggNOG" id="ENOG502TB0V">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000013782"/>
<dbReference type="HOGENOM" id="CLU_104678_0_0_1"/>
<dbReference type="InParanoid" id="Q10589"/>
<dbReference type="OMA" id="KNNASSC"/>
<dbReference type="PhylomeDB" id="Q10589"/>
<dbReference type="TreeFam" id="TF338345"/>
<dbReference type="PathwayCommons" id="Q10589"/>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="684">
<property type="hits" value="6 hits in 847 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="BST2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q10589"/>
<dbReference type="GeneWiki" id="Tetherin"/>
<dbReference type="GenomeRNAi" id="684"/>
<dbReference type="Pharos" id="Q10589">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q10589"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q10589">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000130303">
<property type="expression patterns" value="Expressed in left ovary and 223 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q10589">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q10589">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031225">
<property type="term" value="C:anchored component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035577">
<property type="term" value="C:azurophil granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005771">
<property type="term" value="C:multivesicular body"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0008191">
<property type="term" value="F:metalloendopeptidase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042113">
<property type="term" value="P:B cell activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030336">
<property type="term" value="P:negative regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901253">
<property type="term" value="P:negative regulation of intracellular transport of viral material"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002737">
<property type="term" value="P:negative regulation of plasmacytoid dendritic cell cytokine production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045071">
<property type="term" value="P:negative regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0007001"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070665">
<property type="term" value="P:positive regulation of leukocyte proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032956">
<property type="term" value="P:regulation of actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035455">
<property type="term" value="P:response to interferon-alpha"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035456">
<property type="term" value="P:response to interferon-beta"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034341">
<property type="term" value="P:response to interferon-gamma"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR024886">
<property type="entry name" value="BST2"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15190">
<property type="entry name" value="PTHR15190"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16716">
<property type="entry name" value="BST2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0075">B-cell activation</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0336">GPI-anchor</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0735">Signal-anchor</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Bone marrow stromal antigen 2" id="PRO_0000065005">
<location>
<begin position="1"/>
<end position="161"/>
</location>
</feature>
<feature type="propeptide" description="Removed in mature form" id="PRO_0000253552" evidence="6">
<location>
<begin position="162"/>
<end position="180"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="1"/>
<end position="20"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Signal-anchor for type II membrane protein" evidence="6">
<location>
<begin position="21"/>
<end position="48"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="49"/>
<end position="161"/>
</location>
</feature>
<feature type="coiled-coil region">
<location>
<begin position="68"/>
<end position="152"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="GPI-anchor amidated serine" evidence="6">
<location>
<position position="161"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="12 14 16 19">
<location>
<position position="65"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16 19">
<location>
<position position="92"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain">
<location>
<position position="53"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain">
<location>
<position position="63"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain">
<location>
<position position="91"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="21">
<location>
<position position="18"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_053250" evidence="34">
<location>
<begin position="1"/>
<end position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1804402." id="VAR_012067">
<original>V</original>
<variation>F</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial resistance to Vpu." evidence="30">
<original>STS</original>
<variation>AAA</variation>
<location>
<begin position="3"/>
<end position="5"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial resistance to Vpu and significantly reduced activation of NF-kB; when associated with A-8." evidence="30">
<original>Y</original>
<variation>A</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial resistance to Vpu and significantly reduced activation of NF-kB; when associated with A-6." evidence="30">
<original>Y</original>
<variation>A</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes redistribution to late endosomes in cells expressing KSH virus E3 ubiquitin-protein ligase K5." evidence="21">
<original>K</original>
<variation>R</variation>
<location>
<position position="18"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on redistribution to late endosomes in cells expressing KSH virus E3 ubiquitin-protein ligase K5." evidence="21">
<original>K</original>
<variation>R</variation>
<location>
<position position="21"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents homodimerization and inhibition of SARS-CoV, HCoV-229E, and HIV-1 viral particles production ex vivo; when associated with A-63 and A-91." evidence="33">
<original>C</original>
<variation>A</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents homodimerization and inhibition of SARS-CoV, HCoV-229E, and HIV-1 viral particles production ex vivo; when associated with A-53 and A-91." evidence="33">
<original>C</original>
<variation>A</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation site." evidence="19">
<original>N</original>
<variation>A</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents homodimerization and inhibition of SARS-CoV, HCoV-229E, and HIV-1 viral particles production ex vivo; when associated with A-53 and A-63." evidence="33">
<original>C</original>
<variation>A</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of glycosylation site. Impairs anti-viral activity." evidence="19">
<original>N</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAD96844." ref="4" evidence="34">
<original>N</original>
<variation>D</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="23"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="52"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LK9"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MQ7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MQB"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q811A2"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10329429"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16157322"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18200009"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18342597"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19036818"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19179289"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19564354"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19737401"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19740980"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19837671"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19879838"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20399176"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20419159"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20686043"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20880831"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20940320"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20943977"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21529378"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21621240"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22065321"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22520941"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23028328"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26172439"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26378163"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31199522"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19917491"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26172439"/>
</source>
</evidence>
<sequence length="180" mass="19769" checksum="CAF52340D69061EE" modified="1996-10-01" version="1" precursor="true">MASTSYDYCRVPMEDGDKRCKLLLGIGILVLLIIVILGVPLIIFTIKANSEACRDGLRAVMECRNVTHLLQQELTEAQKGFQDVEAQAATCNHTVMALMASLDAEKAQGQKKVEELEGEITTLNHKLQDASAEVERLRRENQVLSVRIADKKYYPSSQDSSSAAAPQLLIVLLGLSALLQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>